Editorial advisory panel members include:

Jack Aurora, Ph.D., Director, Pharmaceutical Research and Development, Pharmascience Inc.
Professor Dr Jurgen Borlak  Chair, Pahrmaco- and Toxicogenomics, Medical School of Hanover, Fraunhofer Institute
Dr Dalia Cohen  Vice President and Global Head of Functional Genomics, Novartis Institute for Biomedical Research
Damian Counsell  Rosalind Franklin Centre for Genomic Research
Dr. Catherine Fenselau, President of US HUPO (Human Proteome Organisation)
Dr Paul R. Gellert, Senior Principal Scientist, Product Development, Astra Zeneca, Research and Development
Dr Bryn Roberts, Site Head, Discovery Informatics, AstraZeneca
Professor Dr Marco Soria  Chairman, Section for Applied Functional Genomics, European Federation of Biotechnology
Frank Traganos  Treasurer of International Society for Analytical Cytology
Cara Wykowski  Executive Director, The Proteome Society 
John Yates  Department of Cell Biology, The Scripps Research Institute 

Business Briefing: Future Drug Discovery 2006 will contain leading papers and articles written by key global opinion and thought-leaders. The editorial has been designed to provide leading commentary and encourage discussion among this healthcare peer group. Topics will include:

Drug Discovery
Bioinformatics
Genomics
Proteomics
Transgenics
Metabolomics
Screening & Image Analysis
Microarrays
High-throughput Screening
Pharmaceutical Ingredients
Combinatorial Chemistry
Outsourcing
Chromatography
Peptide Synthesis

Proposed Editorial Contributors:

Rolf Apweiler  EMBl Outstation, European Bioinformatics Institute (EBI), Hinxton, Cambridge
Dieter Bimberg  Technical University of Berlin
Professor Dr Jürgen Borlak  Chair, Pharmaco- and Toxicogenomics, Centre of Pharmacology and Toxicology, Medical School of Hanover, Fraunhofer Institute
Dr Dalia Cohen  Vice President, Novartis Institute for Biomedical Research
Dennis Deppe  University of Texas at Austin
Reyna Favis  Senior Scientist, Department of Pharmacogenomics, Johnson & Johnson Pharmaceutical Research & Development
Paolo Fortina  Professor of Medicine, Director, Genomics and Diagnostics Center for Translational Medicine, Thomas Jefferson University
Dr Juergen Hammer Global Head, Bioinformatics, Genetics & Genomics, Roche Pharmaceuticals
Fuchu He  Beijng Institute of Radiation Medicine, Beijing, China; Institutes of Biomedical Sciences,
Dr John Hill  Executive Director, Pharmaceutical Research Institute, Bristol-Myers Squibb
Lukas Huber  Department of Histology and Molecular Cell Biology, Medical, University Innsbruck, Austria
Dr Shiew-Mei Huang  Deputy Office Director for Science, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, (CDER), US Food and Drug Administration (FDA)
Walter H Koch  Senior Director, Pharmacogenetics Department, Roche Molecular Systems
Dr Rebecca Kush  Founder and President, Clinical Data Interchange Standards Consortium 
Joshua LaBaer  Director, Institute of Proteomics, Harvard Medical School.
Dr Zicai Liang  Group Leader, Genomics Technologies, Center for Genomics and Bioinformatics, Karolinska Institute
Professor Jacquie McGlade  European Environment Agency, Denmark
Prof Dr Ing Wolfgang Marquardt  RWTH Aachen, DE
Dr Markus Templin  Head of Microarray Technology, Natural and Medical Science Institute, University of Tubingen
William G Thilly  Biological Engineering Division, Massechusetts Institute of Technology,
Dr Frank Traganos  Treasurer, International Society for Analytical Cytology
Professor Mathias Uhlen  KTH Biotechnology, AlbaNova University Center, Royal Institute of Technology (KTH)
Walter Weiss  Technische Universität München, Dept. of Proteomics, Freising, Germany
Dr Klaus Wilgenbus  Head Corporate Department for Research and Development Licensing, BI

Business Briefing: Future Drug Discovery 2006 will be distributed in December 2005 to a readership of 48,000 (Publisher’s Statement) by name and job title including:

Senior Directors of R&D
Senior Directors of Drug Discovery
Directors of Genomics Programmes
Directors of Proteomics Programmes
Directors of Outsourcing
Directors of Animal Studies
Directors of Product Development
Heads of Business Development
Heads of Drug Development

Media Partnerships

Business Briefings has organised the following media distribution agreements:

Drug Discovery Technology Europe 2006 - IBC Life Sciences
Analytica 2006
CPh Worldwide
Cambridge Healthtech Institute

• Name, address and all contact details, with email link
• URL link to the advertiser’s website
• Corporate logo
• Abstract of the technical article with links to the advertiser’s own corporate website to promote testimonials, products and services, corporate presentations, press releases, and case studies

All specific reader responses will be forwarded to the advertiser within 48 hours. The Touch Briefings Response Unit will forward a monthly comprehensive Response Report to the advertiser in spreadsheet format for ease of integration into your own prospect database.

• Target senior level executives and decision-makers with your advertising message
• Generate enquiries and sales leads from leading industry decision-makers and buyers for your salespeople to follow up on
• Increase your presence at the leading industry trade shows and events ·  Write about the technologies and solutions that you provide
  

• Abstract of the technology article inviting readers to view the article in full, and to draw visitors from Google
• Corporate logo placement
• A hyperlink to your company website
• An e-mail link to your sales department
• Facility to include details of current products and services, press releases and presentations via links to your own company websiteA reader response service in operation for 12 months after publication
• Reader Response Card System
• Carrier Sheet Response System
• Direct e-mail and hyperlink from Supplier ZoneRegular response reports e-mailed directly to your sales department
  
  A complimentary copy of Business Briefing: Future Drug Discovery 2006 report